The Liverpool School of Tropical Medicine (LSTM) and the Centre for Sexual Health and HIV/AIDS Research (CeSHHAR), Zimbabwe are seeking to appoint a Professor at LSTM and Executive Director of CeSHHAR.
CeSHHAR Zimbabwe was founded in 2012 by a group of public health researchers in Zimbabwe in response to the growing need to expand implementation research to accelerate and optimise public health policy and impact in Southern Africa.
Led for the past decade by Professor Frances Cowan, Professor of Global Health, LSTM supported by a senior management team comprising Zimbabwean researchers, programme, data and operations and finance staff, CeSHHAR has gone from strength to strength, expanding its research, programmatic footprint and research capacity strengthening activities. Professor Cowan is stepping down as director but will continue to lead Key Populations research at CeSHHAR.
CeSHHAR aims to conduct research which influences the global HIV and Sexual Health policy environment and strengthens the quality of provision of evidence-based HIV prevention, treatment, and sexual health care. We partner with LSTM, Zimbabwe’s Ministry of Health and Child Care and international and regional centres of research excellence to rigorously evaluate national HIV prevention programmes and determine the impact, uptake and cost effectiveness of novel HIV and sexual and reproductive health interventions.
CeSHHAR works at the forefront of finding innovative solutions to end the AIDS epidemic supported by a range of international donors addressing four thematic areas: Key Populations, Integration of HIV prevention with Sexual and Reproductive Health, Masculinities Studies and Children and Adolescents.
Research at CeSHHAR has facilitated important innovations in implementation of HIV prevention and has contributed to national policy and guideline development. Data generated by CeSHHAR research has been used to inform UNAIDS and Zimbabwe HIV estimates. Most recently CeSHHAR is conducting research to support the regions Covid-19 response.
CeSHHAR employs 260 research, programme and administrative staff. CeSHHAR has a diverse range offunders with an annual budget of US$7,3 Million for the 2020 financial year. Its funders include the Wellcome Trust, the Bill and Melinda Gates Foundation, UK Medical Research Council, Templeton World Charity Foundation, USAID, The Global Fund to Fight AIDS, Tuberculosis and Malaria, UNICEF and UNFPA.
See more of CeSHHAR’s work on its website
LSTM is a centre of excellence in research and postgraduate teaching in the field of tropical medicine. It is the oldest institution of its kind in the world and has been at thefore front of training leaders in global health since 1898.
As we move towards our 125th anniversary in 2023, we will continue to focus on providing high quality scientific evidence and translating our scientific discovery into policies and practices. We do that by working collaboratively in over 70 countries to fulfil our mission of improving the health of the world’spoorest people.
Our worldwide reputation and the calibre of our research outputs has secured funding to lead over 10international consortia and product development partnerships aimed at reducing or eliminating the impactof diseases upon the world’s poorest people.
Our multidisciplinary approach to global health research allows us to translate research innovation and scientific breakthroughs from laboratory research into effective interventions for those most in need, working in partnership with researchers and academic organisations in Low and Middle Income Countries.
Our state-of-the-art facilities continue to develop new drugs, vaccines and pesticides which put us at theforefront of infectious disease research.
As a teaching institution, we attract more than 600 students from 68 countries, from PhD research and Masters programmes to a range of professional courses, and work in partnership with health ministries, universities and research institutions worldwide to train the next generation of doctors, scientists, researchers and health professionals.
LSTM has strong technical expertise in health systems, transfusion and laboratory systems, HIV, tuberculosis, neglected tropical diseases, malaria, monitoring and evaluation, human resources for health, reproductive health and maternal and newborn health.
LSTM Group income now exceeds £500 million and our research portfolio, staff numbers and estate continue to grow.
See more of LSTM’s work on its website